Financhill
Back

Kymera Therapeutics Vs. AIM ImmunoTech Industry Stock Comparison

Sell
47

KYMR
Kymera Therapeutics

Last Price:
42.13
Seasonality Move:
17.88%
Sell
41

AIM
AIM ImmunoTech

Last Price:
0.21
Seasonality Move:
32.76%
Sell
47
Kymera Therapeutics (KYMR) is a Sell

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $42.13. The Score for KYMR is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • KYMR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
AIM ImmunoTech (AIM) is a Sell

Is AIM ImmunoTech a Buy, Sell or Hold?

  • The current AIM ImmunoTech [AIM] share price is $0.22. The Score for AIM is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • AIM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $42.13
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KYMR is experiencing slight buying pressure.

AIM Stock Price Chart

What is AIM ImmunoTech's stock price today?

  • The AIM ImmunoTech share price today is $0.22
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AIM is experiencing buying pressure, which is a positive indicator for future bullish movement.

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.87 Sell
Relative Strength Index (14 RSI): 40.12 Sell
Chaikin Money Flow: 59591 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.06 - 48.4) Sell
Bollinger Bands (100): (43.26 - 48.72) Sell

AIM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 47.54 Sell
Chaikin Money Flow: 270857 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.2 - 0.24) Sell
Bollinger Bands (100): (0.23 - 0.33) Sell

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.35 Sell
20-day SMA: 44.79 Sell
50-day SMA: 46.11 Sell
200-day SMA: 41.35 Buy
8-day EMA: 44.07 Sell
20-day EMA: 45.15 Sell
50-day EMA: 45.78 Sell
200-day EMA: 41.1 Buy

AIM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.21 Buy
20-day SMA: 0.21 Buy
50-day SMA: 0.24 Sell
200-day SMA: 0.34 Sell
8-day EMA: 0.21 Buy
20-day EMA: 0.22 Sell
50-day EMA: 0.24 Sell
200-day EMA: 0.33 Sell

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.12 per share, and a decrease next year of $0.37 per share.

AIM ImmunoTech Earnings Growth & AIM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and a decrease next year of $0.07 per share.

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

AIM ImmunoTech Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):